Astrazeneca (AZN) Asset Utilization Ratio (2009 - 2026)

Astrazeneca's Asset Utilization Ratio history runs 18 years deep, the most recent figure standing at 0.0 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 90.12% year-over-year to 0.0; the TTM figure through Mar 2026 stood at 0.0 (down 90.12% YoY), while the FY2025 annual figure was 0.54, up 2944.64% from the prior year.
• Asset Utilization Ratio was 0.0 for Q1 2026 at Astrazeneca, up from 0.0 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.02 in Q1 2022 to a low of 0.0 in Q4 2025.
• Historically, Asset Utilization Ratio has averaged 0.01 across 5 years, with a median of 0.01 in 2025.
• The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio soared 214.8% in 2024, then plunged 90.19% in 2025.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.01 in 2022, then soared by 96.8% to 0.01 in 2023, then retreated by 28.31% to 0.01 in 2024, then slumped by 90.19% to 0.0 in 2025, then advanced by 3.23% to 0.0 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.0 (Q1 2026), 0.0 (Q4 2025), and 0.01 (Q3 2025), per Business Quant data.